Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.65 +0.00 (+0.68%)
As of: Sep 30, 2026 · 3:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Acquisitions (2015)

Updated

Biodexa Pharmaceuticals' Acquisitions was -$3.84 million in the quarter ended Dec 31, 2015.

Analysis

Biodexa Pharmaceuticals (BDRX) Acquisitions (2015) Analysis & Trends

For the year ended Dec 31, 2015, Acquisitions at Biodexa Pharmaceuticals came in at -$3.87 million.

  • In earlier years, Acquisitions was $189,520 in the year ended Dec 31, 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -17.24 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -3.84 Mn
API Access

Biodexa Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=BDRX&period=max&api_key=YOUR_API_KEY